{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=lispro&page=2", "query": { "intervention": "lispro", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=lispro&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-11T03:34:27.587Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03170544", "title": "Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 1 Diabetes Mellitus", "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "MK-1092, 4.0 nmol/kg", "type": "DRUG" }, { "name": "MK-1092, 8.0 nmol/kg", "type": "DRUG" }, { "name": "MK-1092, 16 nmol/kg", "type": "DRUG" }, { "name": "MK-1092, 32 nmol/kg", "type": "DRUG" }, { "name": "MK-1092, 64 nmol/kg", "type": "DRUG" }, { "name": "Glargine 3.0 nmol/kg", "type": "DRUG" }, { "name": "Lispro 1.2 nmol/kg", "type": "DRUG" }, { "name": "Placebo to glargine", "type": "DRUG" }, { "name": "Placebo to MK-1092", "type": "DRUG" }, { "name": "Dextrose", "type": "OTHER" }, { "name": "Insulin", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "OTHER", "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 69, "start_date": "2017-08-16", "completion_date": "2018-11-08", "has_results": true, "last_update_posted_date": "2019-11-15", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 1, "location_summary": "Chula Vista, California", "locations": [ { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03170544" }, { "nct_id": "NCT05463744", "title": "A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 1 Diabetes", "Diabetes" ], "interventions": [ { "name": "Insulin Efsitora Alfa", "type": "DRUG" }, { "name": "Insulin Degludec", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 692, "start_date": "2022-08-12", "completion_date": "2024-05-07", "has_results": true, "last_update_posted_date": "2025-06-24", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 34, "location_summary": "Concord, California • Fresno, California • Montclair, California + 27 more", "locations": [ { "city": "Concord", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Montclair", "state": "California" }, { "city": "Santa Barbara", "state": "California" }, { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05463744" }, { "nct_id": "NCT01762059", "title": "Outpatient Automated Blood Glucose Control With a Bi-hormonal Bionic Endocrine Pancreas", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "Bi-homonal Bionic Pancreas", "type": "DEVICE" }, { "name": "Usual care", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 32, "start_date": "2013-01", "completion_date": "2014-06", "has_results": true, "last_update_posted_date": "2017-07-21", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01762059" }, { "nct_id": "NCT04112069", "title": "The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type1 Diabetes Mellitus" ], "interventions": [ { "name": "iLet Bionic Pancreas insulin-only configuration with Humalog or Novolog", "type": "DEVICE" }, { "name": "Usual Care", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 20, "start_date": "2018-07-09", "completion_date": "2018-11-19", "has_results": true, "last_update_posted_date": "2020-02-05", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 3, "location_summary": "Palo Alto, California • Aurora, Colorado • Jacksonville, Florida", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04112069" }, { "nct_id": "NCT02227862", "title": "Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Type 1 Diabetes" ], "interventions": [ { "name": "Mylan's insulin glargine", "type": "DRUG" }, { "name": "Lantus®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 558, "start_date": "2014-06", "completion_date": "2016-07", "has_results": true, "last_update_posted_date": "2022-03-03", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 72, "location_summary": "Bell Gardens, California • Fresno, California • Greenbrae, California + 64 more", "locations": [ { "city": "Bell Gardens", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Greenbrae", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02227862" }, { "nct_id": "NCT01686620", "title": "A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "BIOD-123", "type": "DRUG" }, { "name": "Lispro (Humalog)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biodel", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 132, "start_date": "2012-08", "completion_date": "2013-06", "has_results": false, "last_update_posted_date": "2015-07-28", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 34, "location_summary": "Anaheim, California • Chula Vista, California • Concord, California + 28 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Gatos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01686620" }, { "nct_id": "NCT03367390", "title": "A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type1 Diabetes Mellitus" ], "interventions": [ { "name": "AID System", "type": "DEVICE" }, { "name": "Insulin Lispro", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 30, "start_date": "2017-11-08", "completion_date": "2018-02-09", "has_results": false, "last_update_posted_date": "2018-03-15", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 1, "location_summary": "Renton, Washington", "locations": [ { "city": "Renton", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03367390" }, { "nct_id": "NCT06445946", "title": "DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Gestational Diabetes Mellitus", "Pregnancy, High Risk" ], "interventions": [ { "name": "Metformin", "type": "DRUG" }, { "name": "Insulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 1572, "start_date": "2024-08-01", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-06-25", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 24, "location_summary": "Tuscaloosa, Alabama • Los Angeles, California • San Francisco, California + 18 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Newark", "state": "Delaware" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06445946" }, { "nct_id": "NCT03890003", "title": "A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "AID System", "type": "DEVICE" }, { "name": "Insulin Lispro", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 10, "start_date": "2019-03-28", "completion_date": "2019-05-06", "has_results": false, "last_update_posted_date": "2019-06-05", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 1, "location_summary": "Santa Barbara, California", "locations": [ { "city": "Santa Barbara", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03890003" }, { "nct_id": "NCT02603510", "title": "Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin Infusion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Type 1 Diabetes Mellitus" ], "interventions": [ { "name": "SAR342434", "type": "DRUG" }, { "name": "insulin lispro", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "19 Years", "maximum_age": null, "sex": "ALL", "summary": "19 Years and older" }, "enrollment_count": 27, "start_date": "2015-11", "completion_date": "2016-04", "has_results": false, "last_update_posted_date": "2016-05-19", "last_synced_at": "2026-09-11T03:34:27.587Z", "location_count": 2, "location_summary": "Little Rock, Arkansas • Denver, Colorado", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02603510" } ] }